A Comprehensive review on Niosome: a prominent carrier in advance drug delivery

Arun  Kumar; Aparna  Joshi; Ikram  dr; Deepak  Teotia

doi:10.30574/gscbps.2022.18.1.0033

Authors

Arun Kumar Department of Pharmaceutics, Global Institute of Pharmaceutical Education and Research, Kashipur- 244713, Uttarakhand, India.
Aparna Joshi Department of Pharmaceutics, Global Institute of Pharmaceutical Education and Research, Kashipur- 244713, Uttarakhand, India.
Ikram dr Department of Pharmaceutics, Global Institute of Pharmaceutical Education and Research, Kashipur- 244713, Uttarakhand, India.
Deepak Teotia Department of Pharmaceutics, Global Institute of Pharmaceutical Education and Research, Kashipur- 244713, Uttarakhand, India.

DOI:

https://doi.org/10.30574/gscbps.2022.18.1.0033

Keywords:

Niosomes, Surfactant, Hydrophilic, lipophilic drugs

Abstract

Niosomes are vesicular nacarriers that can be used for both amphiphilic and lipophilic drugs. Niosomes are budding vehicles in advanced drug delivery systems. Niosomes are nionic surfactants vesicles that can be formed with or without the addition of cholesterol. Niosomes can be the best choice for nacarriers because of their specific characters like biodegradability, biocompatibility, and immugenic nature. Niosomes can easily trap the hydrophilic and lipophilic drugs and extend the period of the drug in the systemic circulation. Niosomes are the nacarrier that can enhance penetration of drugs into the specific target tissues hence resulting in reduced toxicity. The main aim of this review article is to provide a detailed description of Niosomes.

Metrics

Metrics Loading ...

References

MA Mavaddati, F Moztarzadeh, F Baghbani. “Effectof formulation and processing variables on dexamethasoneentrapment and release of niosomes,” Journal of Cluster Science. 2015; 26(6): 2065–2078.

Elsaied EH, Dawaba HM, Ibrahim EA, Afouna MI. Investigation of proniosomes gel as a promising carrier for transdermal delivery of Glimepiride. Universal Journal of Pharmaceutical Research. 2016; 1(2): 1-10.

Baillie AJ, Coombs GH,Dolan TF. N-ionicsurfactantvesicles, niosomes, as delivery system for the anti-leishmanialdrug, sodium stribogluconateJ.Pharm.Pharmacol. 1986; 38:502-505.

S Sohrabi, A Haeri, A Mahboubi, A Mortazavi, andSDadashzadeh, “Chitosan gel-embedded moxifloxacinniosomes: an efficient antimicrobial hybrid system for burn infection,” International Journal of Biological Macromolecules. 2016; 85: 625–633.

Ugochukwu AE, Nnedimkpa OJ, Rita. Preparation and characterization of Tolterodine tartrate proniosomes, Universal Journal of Pharmaceutical Research. 2017; 2(2): 1-3.

N Shah. “Characterization, optimization and formulation ofniosome containing naproxen,” Journal of Biomedical and Pharmaceutical Research. 2016; 5(1): 1–6.

Ikechukwu UR, John Francis DE, Ambi AA. Development and evaluation of Ritonavir hollow microballoons for floating drug delivery. Universal Journal of Pharmaceutical Research. 2017; 2(2): 8-11.

N Yuksel, ZS Bayindir, EAksakal, AT Ozcelikay. “In situniosome forming maltodextrinproniosomes of candesartancilexetil: in vitro and in vivo evaluations,” International Journalof Biological Macromolecules. 2016; 82: 453–463.

Rahi N, Kumar K. Nasponges: a new era of versatile drug delivery system. Universal Journal of Pharmaceutical Research. 2017; 2(3): 30-33.

Rogerson A, Cummings J, Willmott N, Florence AT. Thedistribution of doxorubicin in mice following administration inniosomes. J Pharm Pharmacol. 1988; 40(5): 337–342.

S. Pawar and P. Vavia, “Glucosamine anchored cancer targetedna-vesicular drug delivery system of doxorubicin,” Journal ofDrugtargeting. 2016; 24(1): 68–79.

Chigbo UJ, Ugochukwu AE, John DF. Dendrimers: a vel tool for drug delivery and targeting. Universal Journal of Pharmaceutical Research. 2017; 2(3): 34-40.

C. Dufes, J.-M. Muller, W. Couet, J.-C. Olivier, I. F. Uchegbu,and A. G. Schatzlein, “Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles,” Pharmaceutical Research. 2004; 21(1): 101–107.

Chauhan N, Kumar K, Pant NC. An updated review on transfersomes: a vel vesicular system for transdermal drug delivery. Universal Journal of Pharmaceutical Research. 2017; 2(4): 42-45.

Malhotra M, Jain NK.Niosomes as Drug Carriers. Indian Drugs. 1994; 31(3): 818866.

Sunday OS. Colon-targeted drug delivery systems: design, trends and approaches. Universal Journal of Pharmaceutical Research. 2017; 2(4): 46-50.

Ijeoma F, Uchegbu, Suresh P, Vyas.N8ionic surfactant basedvesicles (niosomes) in drug delivery. Int. J. Pharm. 1998; 172: 33–70.

Al-kaf AGA, Othman AM. Pharmacosomes: an Updated review, Universal Journal of Pharmaceutical Research. 2017; 2(1): 30-33.

Biju SS., Talegaonkar S., Misra PR., Khar RK., Vesicular systems: Averview. Indian J. Pharm. Sci. 2006; 68: 1418153.

Gurpınar SS, Devrim B, Eryılmaz M. In-vitro antibacterial activity of lactobacilli metabolites loaded hydrogel formulations against pseudomonas aerugisa. Universal Journal of Pharm Research. 2019; 4(4): 9-11.

Rogerson A, Cummings J, Willmott N, Florence AT.Thedistribution of doxorubicin in mice following administration inniosomes. J. Pharm. Pharmacol. 1988, 40: 3378342.

Hand are JN, Madhavi G, Tamhankar BM.Niosomesvel Drug Delivery System. The Eastern Pharmacist. 1994; 37: 61864.

ALGIN YAPAR E, BESKAN U, KARAVANA SY. A recent overview of locally administered topical otic dosage forms. Universal Journal of Pharmaceutical Research. 2019; 4(4): 39-42.